Endovia Health Sciences, Inc. (EDVA) stock
EDVANYSEBeveragesFiscal year ends December 31
$0.16−0.01 (-7.03%)
Close on Nov 12, 2026Market cap $120.89KP/E –Yield –
Endovia Health Sciences profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Endovia Health Sciences's profit margin for the twelve months ending Sep 30, 2025 was -2192.2%. For fiscal 2025 it was -34537.0%, against -2964.9% the year before. The highest annual figure on record is 5.2% in fiscal 2018.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -34537.0% | −31572.2 |
| FY2024 | Dec 31, 2024 | -2964.9% | −2853.4 |
| FY2023 | Dec 31, 2023 | -111.4% | +8.5 |
| FY2022 | Dec 31, 2022 | -119.9% | +136.8 |
| FY2021 | Dec 31, 2021 | -256.7% | +989.9 |
| FY2020 | Dec 31, 2020 | -1246.7% | +23944.6 |
| FY2019 | Dec 31, 2019 | -25191.2% | −25196.4 |
| FY2018 | Dec 31, 2018 | 5.2% | +21.7 |
| FY2017 | Dec 31, 2017 | -16.5% | −11.7 |
| FY2016 | Dec 31, 2016 | -4.8% | −7.0 |
| FY2015 | Dec 31, 2015 | 2.1% | +7.1 |
| FY2014 | Dec 31, 2014 | -5.0% | +1.6 |
| FY2013 | Dec 31, 2013 | -6.5% | −2.4 |
| FY2012 | Dec 31, 2012 | -4.1% | +14.6 |
| FY2011 | Dec 31, 2011 | -18.7% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2026 | Mar 31, 2026 | -50579.3% | −49036.4 |
| Q3 FY2025 | Sep 30, 2025 | -2515.1% | −2034.4 |
| Q2 FY2025 | Jun 30, 2025 | -2297.5% | −1788.6 |
| Q1 FY2025 | Mar 31, 2025 | -5320.9% | −5017.7 |
| Q4 FY2024 | Dec 31, 2024 | -1542.9% | −1319.9 |
| Q3 FY2024 | Sep 30, 2024 | -480.7% | −370.5 |
| Q2 FY2024 | Jun 30, 2024 | -508.9% | −408.8 |
| Q1 FY2024 | Mar 31, 2024 | -303.2% | −197.6 |
| Q4 FY2023 | Dec 31, 2023 | -223.0% | −95.0 |
| Q3 FY2023 | Sep 30, 2023 | -110.2% | +42.4 |
| Q4 FY2022 | Dec 31, 2022 | -100.0% | +99.1 |
| Q3 FY2022 | Sep 30, 2022 | -105.6% | +324.8 |
| Q2 FY2022 | Jun 30, 2022 | -128.0% | +71.5 |
| Q1 FY2022 | Mar 31, 2022 | -152.7% | +55.0 |
| Q4 FY2021 | Dec 31, 2021 | -199.1% | +1885.9 |
| Q3 FY2021 | Sep 30, 2021 | -430.4% | −129.7 |
| Q2 FY2021 | Jun 30, 2021 | -199.5% | −109.1 |
| Q1 FY2021 | Mar 31, 2021 | -207.7% | +2869.6 |
| Q4 FY2020 | Dec 31, 2020 | -2085.0% | −1833.4 |
| Q3 FY2020 | Sep 30, 2020 | -300.7% | −283.1 |
| Q2 FY2020 | Jun 30, 2020 | -90.5% | +420.1 |
| Q1 FY2020 | Mar 31, 2020 | -3077.3% | +23325.1 |
| Q4 FY2019 | Dec 31, 2019 | -251.7% | −246.8 |
| Q3 FY2019 | Sep 30, 2019 | -17.7% | −16.1 |
| Q2 FY2019 | Jun 30, 2019 | -510.6% | −529.6 |
| Q1 FY2019 | Mar 31, 2019 | -26402.4% | −26408.2 |
| Q4 FY2018 | Dec 31, 2018 | -4.9% | +60.6 |
| Q3 FY2018 | Sep 30, 2018 | -1.6% | −12.7 |
| Q2 FY2018 | Jun 30, 2018 | 19.1% | +28.2 |
| Q1 FY2018 | Mar 31, 2018 | 5.8% | +35.3 |
| Q4 FY2017 | Dec 31, 2017 | -65.4% | −60.4 |
| Q3 FY2017 | Sep 30, 2017 | 11.1% | +16.1 |
| Q2 FY2017 | Jun 30, 2017 | -9.1% | −4.1 |
| Q1 FY2017 | Mar 31, 2017 | -29.5% | – |
| Q4 FY2016 | Dec 31, 2016 | -5.0% | – |
| Q3 FY2016 | Sep 30, 2016 | -5.0% | – |
| Q2 FY2016 | Jun 30, 2016 | -5.0% | – |
See a number that looks wrong?